These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24509204)

  • 1. A randomized, controlled, crossover study of sacral nerve stimulation for irritable bowel syndrome.
    Fassov JL; Lundby L; Laurberg S; Buntzen S; Krogh K
    Ann Surg; 2014 Jul; 260(1):31-6. PubMed ID: 24509204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary sacral nerve stimulation for treatment of irritable bowel syndrome: a pilot study.
    Lundby L; Krogh K; Buntzen S; Laurberg S
    Dis Colon Rectum; 2008 Jul; 51(7):1074-8. PubMed ID: 18418655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year follow-up of sacral nerve stimulation for patients with diarrhoea-predominant and mixed irritable bowel syndrome.
    Fassov J; Lundby L; Laurberg S; Buntzen S; Krogh K
    Colorectal Dis; 2017 Feb; 19(2):188-193. PubMed ID: 27328645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral nerve modulation for irritable bowel syndrome: A randomized, double-blinded, placebo-controlled crossover study.
    Fassov J; Lundby L; Laurberg S; Krogh K
    Neurogastroenterol Motil; 2019 Jun; 31(6):e13570. PubMed ID: 30793441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral nerve stimulation changes rectal sensitivity and biomechanical properties in patients with irritable bowel syndrome.
    Fassov J; Brock C; Lundby L; Drewes AM; Gregersen H; Buntzen S; Laurberg S; Krogh K
    Neurogastroenterol Motil; 2014 Nov; 26(11):1597-604. PubMed ID: 25223743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
    Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
    Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, controlled study of small intestinal motility in patients treated with sacral nerve stimulation for irritable bowel syndrome.
    Fassov J; Lundby L; Worsøe J; Buntzen S; Laurberg S; Krogh K
    BMC Gastroenterol; 2014 Jun; 14():111. PubMed ID: 24965754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.
    Johannesson E; Simrén M; Strid H; Bajor A; Sadik R
    Am J Gastroenterol; 2011 May; 106(5):915-22. PubMed ID: 21206488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
    J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ
    Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of irritable bowel syndrome with osteopathy: results of a randomized controlled pilot study.
    Hundscheid HW; Pepels MJ; Engels LG; Loffeld RJ
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1394-8. PubMed ID: 17716344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
    Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M
    Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
    Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
    Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
    Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
    Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA; Covington PS; Patrick DL
    Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life.
    Böhn L; Störsrud S; Törnblom H; Bengtsson U; Simrén M
    Am J Gastroenterol; 2013 May; 108(5):634-41. PubMed ID: 23644955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative observation on therapeutic effects between acupuncture and western medication for diarrhea-predominant irritable bowel syndrome].
    Li H; Pei LX; Zhou JL
    Zhongguo Zhen Jiu; 2012 Aug; 32(8):679-82. PubMed ID: 23072079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.